Moreover, mutations in the CTLA-4, PD1, PTPN22, CD14, CD40, and IL2R genes, as well as in thyroid-specific genes such as those encoding the TSH receptor and thyroglobulin, have been linked to HT susceptibility (21, 23–25). This evidence concerns the gene TG and hematocrit.